Moreover, PI3K/AKT signaling is involved in the induction and expression of a gene encoding a protein conferring multidrug resistance, which is conspicuously associated with cancer therapy antagonism, a major obstacle in the effective chemotherapy of cancer. The gene discussed is AKT1; the disease is cancer.